Screening Protocol for the Evaluation of Research Participants

NCT01036217 | Completed

• 2 other identifiers: 99990641206-DA-N412
• Study Type: observational
• Target: 55,000
• Locations: 1 country
• Sites: 1

Brief Summary

Background: \- The National Institute on Drug Abuse (NIDA) uses a standardized set of procedures to develop a pool of potential participants for research studies. Because some of the data collected during screening are used later for research, the screening itself is considered a study. An applicant to any NIDA study is considered a participant in NIDA screening. Objectives: \- To identify, recruit, and screen participants for NIDA research protocols. Eligibility: \- Individuals 18 years of age and older who are able to provide informed consent. Design:

• Individuals who are eligible for screening will undergo two interviews: a telephone interview and an in-person interview. The phone interview will determine eligibility for the in-person interview.
• The in-person interview may require up to five visits to NIDA. The in-person visit will involve any or all of the following procedures: (1) full physical examination and medical history; (2) psychiatric interview; (3) psychological testing; (4) electrocardiogram; (5) samples of blood, urine, and hair; and (6) other minimally invasive procedures as directed by the research staff.
• During screening, a photograph will be taken for confirmation of identity during subsequent visits for other studies.
• No clinical care will be provided as part of screening.

Conditions

Substance Abuse; Disorders

Keywords

Recruitment; Adult; Telephone; Selection; Testing

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults (at least age 18)
• Ability to understand and answer the questions as posed.

You may not qualify if:

• \. Inability to provide valid informed consent.

Sponsors & Collaborators

• National Institute on Drug Abuse (NIDA): lead

Study Sites (1)

National Institute on Drug Abuse, Biomedical Research Center (BRC)

Baltimore, Maryland, 21224, United States

Location

MeSH Terms

Conditions

Substance-Related Disorders; Disease

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders; Mental Disorders; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: observational
• Time Perspective: PROSPECTIVE
• Sponsor Type: NIH

Study Record Dates

• First Submitted: December 18, 2009
• First Posted: December 21, 2009
• Study Start: May 17, 2006
• Study Completion: June 17, 2010
• Last Updated: July 2, 2017

Record last verified: 2010-06-17

Locations

US (1)